News tagged with hemophilia
Scientist discovers natural molecule indirectly prevents stable clot formation
A scientist from The Scripps Research Institute has identified a new role for a natural signaling molecule in preventing blood clot formation. The molecule could become a target for the development of novel and cost-effective ...
Feb 01, 2011 |
not rated yet |
0
|
Medicine may be key to cloning's future
The cloning of animals may have come from agriculture, but its real promise may be in the lucrative field of medicine rather than as food.
Aug 17, 2010 |
5 / 5 (7) |
0
Jumping Genes Provide Extensive 'Raw Material' for Evolution, Study Finds
(PhysOrg.com) -- Using high-throughput sequencing to map the locations of a common type of jumping gene within a person's entire genome, researchers at the University of Pennsylvania School of Medicine found extensive variation ...
Jun 01, 2010 |
5 / 5 (6) |
0
|
Researchers harness the power of plants to fight hemophilia
(PhysOrg.com) -- Hemophilia, a disease linked with legends of European monarchs, frail heirs and one flamboyant charlatan called Rasputin, still afflicts many people today. And the very treatments that can help can also put ...
Medicine & Health / Medical research
Mar 30, 2010 |
4 / 5 (1) |
0
|
Early safety results promising for Phase I/II trial of gene therapy treatment of hemophilia B
Investigators report no evidence of toxicity in the four hemophilia B patients enrolled to date in a gene therapy trial using a vector under development at St. Jude Children's Research Hospital and UCL (University College ...
Medicine & Health / Medical research
Dec 06, 2010 |
not rated yet |
0
New animal model for hemophilia A developed
(PhysOrg.com) -- Researchers at Yale School of Medicine have developed a new animal model for studying hemophilia A, with the goal of eventually treating people with the disorder. Hemophilia A, a hereditary defect that prevents ...
Medicine & Health / Diseases, Conditions, Syndromes
Sep 03, 2010 |
not rated yet |
0
Adding a genetic supertool: Genome Analyzer fuels research dreams and tomorrow's cures
To identify the hemophilia mutation that affected Queen Victoria and her European relatives, scientific detectives used a cutting-edge "deep sequencing tool." Able to trace rare genetic disease mutations, the tool can turn ...
Dec 22, 2009 |
5 / 5 (1) |
0
Technique may help stem cells generate solid organs
Stem cells can thrive in segments of well-vascularized tissue temporarily removed from laboratory animals, say researchers at the Stanford University School of Medicine. Once the cells have nestled into the tissue's nooks ...
Medicine & Health / Medical research
Mar 02, 2009 |
5 / 5 (1) |
0
Hemostatic drug less effective than originally predicted
The use of recombinant activated factor 7 (rFVIIa) a drug used to treat bleeding in hemophiliacs in patients without hemophilia is not recommended because of the potential for adverse events, found a study published ...
Medicine & Health / Medications
Nov 15, 2010 |
not rated yet |
0
Research highlights need to address hemophilia in developing world
When modern medicine finds a way to treat a medical condition, people often think that the problem is solved. But we also have to find ways to get that treatment into the hands of those who need it. For example, new research ...
Medicine & Health / Diseases, Conditions, Syndromes
Nov 16, 2009 |
not rated yet |
0
Induced pluripotent stem cells repair heart, study shows
In a proof-of-concept study, Mayo Clinic investigators have demonstrated that induced pluripotent stem (iPS) cells can be used to treat heart disease. iPS cells are stem cells converted from adult cells. In this study, the ...
Medicine & Health / Medical research
Jul 20, 2009 |
5 / 5 (1) |
0
Haemophilia
Haemophilia (English pronunciation: /hiːməˈfɪliə/; also spelled hemophilia in North America, from the Greek haima αἷμα 'blood' and philia φιλος 'love') is a group of hereditary genetic disorders that impair the body's ability to control blood clotting or coagulation, which is used to stop bleeding when a blood vessel is broken. Haemophilia A (clotting factor VIII deficiency) is the most common form of the disorder, present in about 1 in 5,000–10,000 male births. Haemophilia B (factor IX deficiency) occurs in around 1 in about 20,000–34,000 female births.
Like most recessive sex-linked, X chromosome disorders, haemophilia is more likely to occur in males than females. This is because females have two X chromosomes while males have only one, so the defective gene is guaranteed to manifest in any male who carries it. Because females have two X chromosomes and haemophilia is rare, the chance of a female having two defective copies of the gene is very low, so females are almost exclusively asymptomatic carriers of the disorder. Female carriers can inherit the defective gene from either their mother or father, or it may be a new mutation. Although it is not impossible for a female to have haemophilia, it is unusual: a female with Haemophilia A or B would have to be the daughter of both a male haemophiliac and a female carrier, while the non-sex-linked Haemophilia C, which can affect either sex, is extremely rare.
Haemophilia lowers blood plasma clotting factor levels of the coagulation factors needed for a normal clotting process. Thus when a blood vessel is injured, a temporary scab does form, but the missing coagulation factors prevent fibrin formation, which is necessary to maintain the blood clot. A haemophiliac does not bleed more intensely than a person without it, but can bleed for a much longer time. In severe haemophiliacs even a minor injury can result in blood loss lasting days or weeks, or even never healing completely. In areas such as the brain or inside joints, this can be fatal or permanently debilitating.
For more information about Haemophilia, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.